Basic Information
RNALocate ID: RLID:11002475
RNA Symbol: hsa-miR-370-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-370
RNA ID: miRBase:MIMAT0000722
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002029 Cytoplasm Cervical cancer cell lines (HeLa|SiHa) 31703640
RLID:01002030 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002472 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11002473 Exosome Jurkat-derived T cell line (J77cl20) 21505438
RLID:11002474 Exosome Brain tissue 23382797
RLID:11002476 Microvesicle Follicular fluid 23666971
RLID-D:11000412 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001200 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-370-3p Oral squamous cell carcinoma MNDR-E-MI-44981
MNDR hsa-miR-370-3p Medulloblastoma MNDR-E-MI-44982
MNDR hsa-miR-370-3p High-grade serous ovarian carcinoma MNDR-E-MI-44983
MNDR hsa-miR-370-3p Uterine corpus endometrial carcinoma MNDR-E-MI-44984
MNDR hsa-miR-370-3p Lymphoma MNDR-E-MI-44985
MNDR hsa-miR-370-3p Non-hodgkin lymphoma MNDR-E-MI-44986
MNDR hsa-miR-370-3p Estrogen-receptor positive breast cancer MNDR-E-MI-44987
MNDR hsa-miR-370-3p Estrogen-receptor negative breast cancer MNDR-E-MI-44988
MNDR hsa-miR-370-3p Progesterone-receptor positive breast cancer MNDR-E-MI-44989
MNDR hsa-miR-370-3p Progesterone-receptor negative breast cancer MNDR-E-MI-44990
MNDR hsa-miR-370-3p Her2-receptor positive breast cancer MNDR-E-MI-44991
MNDR hsa-miR-370-3p Anencephaly MNDR-E-MI-44992
MNDR hsa-miR-370-3p Neurofibromatosis 1 MNDR-E-MI-44993
MNDR hsa-miR-370-3p Dermatomyositis MNDR-E-MI-44994
MNDR hsa-miR-370-3p Prostate cancer MNDR-E-MI-44995
MNDR hsa-miR-370-3p Gastric cancer MNDR-E-MI-44996
MNDR hsa-miR-370-3p Alzheimer disease MNDR-E-MI-44997
MNDR hsa-miR-370-3p Intracranial aneurysm MNDR-E-MI-44998
MNDR hsa-miR-370-3p Dysautonomia familial MNDR-E-MI-44999
MNDR hsa-miR-370-3p Brain cancer MNDR-E-MI-45000
MNDR hsa-miR-370-3p Lung cancer MNDR-E-MI-45001
MNDR hsa-miR-370-3p Parkinson disease MNDR-E-MI-45002
MNDR hsa-miR-370-3p Breast cancer MNDR-E-MI-45003
MNDR hsa-miR-370-3p Pituitary neoplasms MNDR-E-MI-45004
MNDR hsa-miR-370-3p Pancreatic cancer MNDR-E-MI-45005
MNDR hsa-miR-370-3p Rectum adenocarcinoma MNDR-E-MI-45006
MNDR hsa-miR-370-3p Colon cancer MNDR-E-MI-45007
MNDR hsa-miR-370-3p Colon adenocarcinoma MNDR-E-MI-45008
MNDR hsa-miR-370-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-45009
MNDR hsa-miR-370-3p Ovarian cancer MNDR-E-MI-45010
MNDR hsa-miR-370-3p Prostate adenocarcinoma MNDR-E-MI-45011
MNDR hsa-miR-370-3p Carcinoma ductal breast MNDR-E-MI-45012
MNDR hsa-miR-370-3p Glioblastoma MNDR-E-MI-45013
MNDR hsa-miR-370-3p Glioma MNDR-E-MI-45014
MNDR hsa-miR-370-3p Amyotrophic lateral sclerosis MNDR-E-MI-45015
MNDR hsa-miR-370-3p Osteosarcoma MNDR-E-MI-45016
MNDR hsa-miR-370-3p Coronary artery disease MNDR-E-MI-45017
MNDR hsa-miR-370-3p Meningioma MNDR-E-MI-45018
MNDR hsa-miR-370-3p Cervical adenocarcinoma MNDR-E-MI-45019
MNDR hsa-miR-370-3p Cervical squamous cell carcinoma MNDR-E-MI-45020
MNDR hsa-miR-370-3p Bone-invasive pituitary adenoma MNDR-E-MI-45021
MNDR hsa-miR-370-3p Lung squamous cell carcinoma MNDR-E-MI-45022
MNDR hsa-miR-370-3p Carcinoma lung non-small-cell MNDR-E-MI-45023
MNDR hsa-miR-370-3p Lung adenocarcinoma MNDR-E-MI-45024
MNDR hsa-miR-370-3p Adrenocortical carcinoma MNDR-E-MI-45025
MNDR hsa-miR-370-3p Ovarian carcinoma MNDR-E-MI-45026
MNDR hsa-miR-370-3p Bladder urothelial carcinoma MNDR-E-MI-45027
MNDR hsa-miR-370-3p Pancreatic adenocarcinoma MNDR-E-MI-45028
MNDR hsa-miR-370-3p Carcinoma renal cell MNDR-E-MI-45029
MNDR hsa-miR-370-3p Kidney renal papillary cell carcinoma MNDR-E-MI-45030
MNDR hsa-miR-370-3p Renal clear cell carcinoma MNDR-E-MI-45031
MNDR hsa-miR-370-3p Biliary tract cancer MNDR-E-MI-45032
MNDR hsa-miR-370-3p Cholangiocarcinoma MNDR-E-MI-45033
MNDR hsa-miR-370-3p Esophageal cancer MNDR-E-MI-45034
MNDR hsa-miR-370-3p Synovial sarcoma MNDR-E-MI-45035
MNDR hsa-miR-370-3p Head and neck squamous cell carcinoma MNDR-E-MI-45036
MNDR hsa-miR-370-3p Breast invasive carcinoma MNDR-E-MI-45037
MNDR hsa-miR-370-3p Hepatocellular carcinoma MNDR-E-MI-45038
MNDR hsa-miR-370-3p B-cell non-hodgkin lymphoma MNDR-E-MI-45039
MNDR hsa-miR-370-3p Retinoblastoma MNDR-E-MI-45040
MNDR hsa-miR-370-3p Chronic fatigue syndrome MNDR-E-MI-45041
MNDR hsa-miR-370-3p Hodgkin disease MNDR-E-MI-45042
MNDR hsa-miR-370-3p Acute myeloid leukemia MNDR-E-MI-45043
MNDR hsa-miR-370-3p Colorectal cancer MNDR-E-MI-45044
MNDR hsa-miR-370-3p Nasopharynx carcinoma MNDR-E-MI-45045
MNDR hsa-miR-370-3p Multiple myeloma MNDR-E-MI-45046
MNDR hsa-miR-370-3p Nasopharyngeal cancer MNDR-E-MI-45047
MNDR hsa-miR-370-3p Prostatic neoplasms MNDR-E-MI-45048
MNDR hsa-miR-370-3p Stroke lacunar MNDR-E-MI-45049
MNDR hsa-miR-370-3p Breast cancer her3+ negative MNDR-E-MI-45050
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CCNE2 Homo sapiens RR00295455
TOP